IMPORTANT SAFETY INFORMATION: POSSIBLE THYROID TUMORS, INCLUDING CANCER:
In animal studies, BYDUREON caused rats to develop tumors of the thyroid gland. Some of these tumors were cancer. It is not known if BYDUREON causes thyroid tumors or a type of thyroid cancer called medullary thyroid cancer (MTC) in people. Do not take BYDUREON if you or any of your family members have MTC or if you have Multiple Endocrine Neoplasia syndrome type 2. While taking BYDUREON, tell your healthcare provider if you get a lump or swelling in your neck, hoarseness, trouble swallowing, or shortness of breath. These may be symptoms of thyroid cancer.
Please click here for additional Important Safety Information.
As an adult with type 2 diabetes, you try hard to keep your blood sugar under control. So you make an effort to eat healthier, be active, and take your medicines as your doctor prescribes. But your blood sugar level still may not be where you and your healthcare provider want it to be. It may be time to ask your healthcare provider about BYDUREON (exenatide extended-release for injectable suspension).
Do not take BYDUREON if you have had an allergic reaction to exenatide or any of the other ingredients in BYDUREON. Severe allergic reactions can happen with BYDUREON. Symptoms of a severe allergic reaction to BYDUREON are severe rash or itching, swelling of your face, lips, and throat that may cause difficulty breathing or swallowing, feeling faint or dizzy and very rapid heartbeat. If you have any symptoms of a severe allergic reaction, stop taking BYDUREON and call your healthcare provider right away.
BYDUREON is an injectable prescription medicine that may improve blood sugar (glucose) in adults with type 2 diabetes mellitus, and should be used along with diet and exercise. BYDUREON is not recommended as the first medication to treat diabetes.
BYDUREON is a long-acting form of the medication in BYETTA® (exenatide) injection so both drugs should not be used together. BYDUREON is not a substitute for insulin and has not been studied in combination with insulin. BYDUREON is not for people with type 1 diabetes or people with diabetic ketoacidosis (a condition caused by very high blood sugar). BYDUREON is not recommended for use in children. It is not known if BYDUREON is safe and effective in people with a history of pancreatitis or severe kidney problems.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Bristol-Myers Squibb, Amylin Pharmaceuticals, LLC, and AstraZeneca do not review the information on this website and/or database for content, accuracy, or completeness. Use of and access to this information is subject to the terms, limitations, and conditions set by the website and/or database producer.
Bristol-Myers Squibb, Amylin Pharmaceuticals, and AstraZeneca make no representation as to the accuracy or any other aspect of the information contained on such website and/or database, nor does Bristol-Myers Squibb or AstraZeneca necessarily endorse such website and/or database.
Click "Continue" to proceed or "Return" to return to this website.